Unexplored Factors in Medication Wastage: Investigating Economic Impact in a Brazilian Teaching Hospital
Authors:
- Yago Marcos Pessoa‐GonçalvesYago Marcos Pessoa‐Gonçalves
- Victor Hugo Palhares Flávio‐ReisVFVictor Hugo Palhares Flávio‐Reis
- Jacqueline Cristiane CostaJCJacqueline Cristiane Costa
- Daniela Ramos TostesDTDaniela Ramos Tostes
- Chamberttan Souza DesidérioCDChamberttan Souza Desidério
- Guilherme Costa GattoGGGuilherme Costa Gatto
- Carlo José Freire de OliveiraCOCarlo José Freire de Oliveira
- 19 July 2026
- journal article
- research article
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 32 (5) , e70530
Abstract
Rationale: Medication wastage is a persistent challenge in healthcare systems, yet the economic impact of syringe dead space (DS) and residual volume during routine medication administration remains underexplored outside the vaccine context. Aims and Objectives: To investigate the economic impact of syringe dead space and residual volume on medication administration in a Brazilian teaching hospital. Method: A retrospective observational study was conducted using medication prescription data from 2022 at the Hospital de Clínicas da Universidade Federal do Triângulo Mineiro, Brazil. All injectable medications were included. Medication cost per millilitre was calculated using hospital procurement records. Syringe sizes were defined according to prescribed volumes. Syringe dead space was measured using an analytical balance (ATY224, Shimadzu, Japan), and wasted volumes and financial losses were estimated. The medication wastage rate was calculated as the ratio between wasted value and total medication expenditure. Results: A total of 120 medications met the inclusion criteria, accounting for 693,933 prescriptions. The estimated wasted volume due to residual volume was 41,394.47 mL. The top ten medications accounted for 51.72% of prescriptions and 48.18% of the wasted financial value. The overall hospital wastage rate was approximately 1.16%. Syringe dead space, frequency of medication administration, and cost per millilitre were identified as the main contributors to medication wastage. Conclusion: Syringe dead space and residual volume constitute a measurable and avoidable source of medication loss, with relevant economic implications. These findings can inform procurement strategies, waste reduction interventions, and public health policies aimed at optimising healthcare resource use.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (445498/2023‐4)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (314015/2021‐3)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
This publication has 29 references indexed in Scilit:
- COVID-19 vaccination: effective utilization of low dead space (LDS) syringesInternational Journal of Infectious Diseases, 2021
- Increasing vaccine supply with low dead-volume syringes and needlesInternational Journal of Pharmaceutics, 2021
- Economic Impact of Emergency Visits due to Drug-Related Morbidity on a Brazilian HospitalValue in Health Regional Issues, 2017
- Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)Vaccine, 2017
- Taking stock of medication wastage: Unused medications in US householdsResearch in Social and Administrative Pharmacy, 2015
- A systematic review of the literature on ‘medication wastage’: an exploration of causative factors and effect of interventionsInternational Journal of Clinical Pharmacy, 2014
- Gastos do Ministério da Saúde do Brasil com Medicamentos de Alto Custo: Uma Análise Centrada no PacienteValue in Health, 2011
- An economic assessment of the extent of medication use and wastage among families in Saudi Arabia and Arabian Gulf countriesClinical Therapeutics, 2003
- OctreotideNew England Journal of Medicine, 1996
- WASTAGE OF PHARMACEUTICALSThe Lancet, 1976